US Physical Therapy (USPH) Stock: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$85.83
-0.74 (-0.85%)
âŧ
5d:
-3.05%
30d:
+3.91%
90d:
+10.31%
WAIT
LOW Confidence
Analysis Updated: Oct 30, 2026 12:00 AM ET
Earnings: Nov 04, 2026
3d
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At 3.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At 3.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$123.81
Based on 9.6% avg growth
INTRINSIC VALUE TODAY
$76.88
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $85.83, which is considered fair relative to its 30-day fair value range of $83.58 to $87.01. The stock's valuation (Forward PE: 25.8) is in line with its historical norms (23.6). At these levels, the market is pricing in 3.0% annual earnings growth.
Technical Outlook: Technically, USPH is in a strong uptrend. Immediate support is located at $79.76, while resistance sits at $89.98.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $97.83 (+14.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, USPH is in a strong uptrend. Immediate support is located at $79.76, while resistance sits at $89.98.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $97.83 (+14.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$83.58 -
$87.01
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($97.83)
- BULLISH: Expecting earnings turnaround to 3.0% growth with 8.5% revenue growth
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$83.58 -
$87.01
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$79.76
Resistance Level
$89.98
Current Trend
Strong Uptrend
Technical data as of
Oct 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.79
Wall Street Target
$97.83
(+14.0%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
-56.5%
Profit Margin
4.0%
Valuation Premium vs History
+3.0% premium
PE vs Historical
25.8 vs 23.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$88.40
(+3%)
2-Year Target
$91.06
(+6%)
3-Year Target
$93.79
(+9%)
3-Yr Target (if PE normalizes)
(PE: 26â24)
PE COMPRESSION
$85.83
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.8, Growth: 15.2%)
$131.38
(+53%)
Base:
(SPY PE: 19.9, Growth: 15.2%)
$101.18
(+18%)
Bear:
(PE: 16.9, Growth: 15.2%)
$86.00
(+0%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Forward PE: 28.01 | Forward EPS (Implied): $3.06
Bull Case
$103.64
(+21%)
Analyst growth 15.0%, PE expands to 29.4
Base Case
$85.83
(0%)
Market implied 0.0%, PE stable at 28.0
Bear Case
$65.66
(-24%)
Severe decline -15.0%, PE contracts to 25.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 31, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
Data refreshes hourly during market hours. Next update: 4:09 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
23 analysts |
$286 | 64 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$462 | 45 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 45 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 53 HOLD |
|
CON
Concentra Group HoldingsâĻ |
STRONG BUY
11 analysts |
$42 | 41 HOLD |
